MetLife, Inc.

Valuation Analysis

About the Company

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, struc

MetLife, Inc. Stock at a Glance

MetLife, Inc. (MET) is currently trading at $88.84 with a market capitalization of $57.2B. The trailing P/E ratio stands at 17.18x, with a forward P/E of 8.08x. The 52-week range spans from $67.33 to $89.44; the current price is 0.7% below the yearly high. Year-over-year revenue growth stands at +2.7%. The net profit margin stands at 4.67%.

💰 Dividend

MetLife, Inc. pays an annual dividend of $2.37 per share, representing a yield of 2.67%. The payout ratio stands at 43.91%.

📊 Analyst Rating

16 analysts rate MetLife, Inc. (MET) on consensus: Buy. The average price target is $92.00, implying +3.56% from the current price. Analyst price targets range from $75.00 to $106.00.

MetLife, Inc.: The Investment Case in Detail

MetLife, Inc. (MET) operates in the Financial Services — specifically Insurance - Life — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Earnings growth of 35.9% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

The Bear Case

Revenue growth has slowed to just 2.7%, which is below nominal GDP — the business is no longer outgrowing the broader economy. With a net margin of just 4.67%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valuation in Context

With a PEG ratio of 0.47, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

What to Watch Next

• The forward P/E of 8.08x is meaningfully below the trailing 17.18x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 97.3% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy MetLife, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.